Article

miR-29a-3p in Exosomes from Heme Oxygenase-1 Modified Bone Marrow Mesenchymal Stem Cells…

Oxidative Medicine and Cellular Longevity · 2022 · Xiang Li, author Longlong Wu, author Xuan Tian, author Weiping Zheng, author Mengshu Yuan, author Xiaorong Tian, author Huaiwen Zuo, author Hongli Song, author Zhongyang Shen, author Chaoliang Tang, Academic Editor

Key facts

Title miR-29a-3p in Exosomes from Heme Oxygenase-1 Modified Bone Marrow Mesenchymal Stem Cells Alleviates Steatotic Liver Ischemia-Reperfusion Injury in Rats by Suppressing Ferroptosis via Iron Responsive Element Binding Protein 2
First author Xiang Li, author Longlong Wu, author Xuan Tian, author Weiping Zheng, author Mengshu Yuan, author Xiaorong Tian, author Huaiwen Zuo, author Hongli Song, author Zhongyang Shen, author Chaoliang Tang, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Feb 11, 2022
DOI 10.1155/2022/6520789
Devices mentioned K000534, K003865, K012371, K021512, K023296, K024098, K031824, K031879, K032377, K033009, K033185, K051890 and 38 more
Product codes mentioned CDS, CEM, CGA, CGZ, CHL, CHN, CIT, DDG, DLJ, GIA, GKR, JIL and 39 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature